DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Mamikonyan E, Xie SX, Melvin E, Weintraub D.
Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study.
Mov Disord 2015;
30 (07) 912-918
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.